Clinical trial

A Comparison of Epidural and Intravenous Patient-Controlled Analgesia Following Lumbar Spinal Fusion Surgery: A Prospective Randomized Study

Name
STU 092016-061
Description
Postoperative analgesia following spine surgery is difficult to manage. Current treatment modalities rely heavily on opioid analgesics with all of the inherent limitations and side effects. While current best practice focuses on a 'multimodal approach' (i.e. using multiple different drugs and techniques to control pain after surgery), there is no consensus regarding which components of this multimodal therapy provide optimal analgesia. This prospective randomized study will enroll patients undergoing elective Lumbar Spinal Fusion Surgery at Zale Lipshy University Hospital. The primary objective is to determine the comparative efficacy of epidural analgesia, as compared with intravenous (IV) patient-controlled analgesia (PCA), on post-operative analgesia.
Trial arms
Trial start
2017-05-08
Estimated PCD
2022-08-18
Trial end
2023-04-04
Status
Terminated
Phase
Early phase I
Treatment
Bupivacaine
Bupivacaine (0.0625%) will be combined with fentanyl for postoperative epidural analgesia via a lumbar epidural catheter
Arms:
Patient-Controlled Epidural Analgesia
Other names:
Bupivacaine Hydrochloride
Hydromorphone
Hydromorphone will be given continuous infusion for intravenous patient controlled analgesia (syringe 25 mg/50 mL).
Arms:
Intravenous patient-controlled analgesia
Other names:
DILAUDID
Fentanyl
Fentanyl (2 mcg/ml) will be given via epidural route together with bupivacaine.
Arms:
Patient-Controlled Epidural Analgesia
Other names:
Opioid
Size
46
Primary endpoint
Visual Analog Pain Score (VAS)
VAS score at postoperative 24 hours
Eligibility criteria
Inclusion Criteria: * Adult subjects aged 18 years or older * Scheduled for elective posterior lumbar spinal fusion surgery between 1 and 3 levels Exclusion Criteria: * Baseline cognitive deficits sufficient to make objective pain self-assessments unreliable in the estimation of the Study Investigators. * Immunocompromised subject * Coagulopathy * Severe liver and renal dysfunction * Preoperative neurological deficits * The dura damage during surgery * Inability to follow directions or comprehend the English language. * Females who are pregnant as determined by positive pregnancy test on or before the day of surgery. * Prisoners. * Patient refusal to provide informed consent. * Allergy to amide local anesthetics (lidocaine, bupivacaine, ropivacaine) or opioid (fentanyl) allergy if patient assigned epidural analgesia. * Hydromorphone allergy if patient assigned IV PCA
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 46, 'type': 'ACTUAL'}}
Updated at
2023-10-26

1 organization

3 products

1 indication

Indication
Pain
Product
Fentanyl